Viatris Inc - ESG Rating & Company Profile powered by AI
If you work at Viatris Inc and you wish to licence your Sustainability rating, please contact us. This report of Viatris Inc incorporates intelligence from across the web and also from public documents by Viatris Inc. The ESG score for Viatris Inc indicates its transparency towards the United Nations Sustainable Development Goals.
Viatris Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.3; made up of an environmental score of 7.0, social score of 7.0 and governance score of 8.0.
7.3
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 160 | YungShin Global Holding Corp | 7.5 | High |
| 160 | Zentiva SA | 7.5 | High |
| 191 | Viatris Inc | 7.3 | High |
| 191 | Cellectis SA | 7.3 | High |
| 191 | Aurinia Pharmaceuticals Inc | 7.3 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Viatris Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Viatris Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Viatris Inc report the average age of the workforce?
Sign up for free to unlockDoes Viatris Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Viatris Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Viatris Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Viatris Inc offer flexible work?
Sign up for free to unlockDoes Viatris Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Viatris Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Viatris Inc conduct supply chain audits?
Sign up for free to unlockDoes Viatris Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Viatris Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Viatris Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Viatris Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Viatris Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Viatris Inc disclose water use targets?
Sign up for free to unlockDoes Viatris Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Viatris Inc have a product recall in the last two years?
Sign up for free to unlockDoes Viatris Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Viatris Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Viatris Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Viatris Inc disclose parental leave metrics?
Sign up for free to unlockDoes Viatris Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Viatris Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Viatris Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Viatris Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Viatris Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Viatris Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Viatris Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Viatris Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Viatris Inc disclose its waste policy?
Sign up for free to unlockDoes Viatris Inc report according to TCFD requirements?
Sign up for free to unlockDoes Viatris Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Viatris Inc disclose energy use targets?
Sign up for free to unlockDoes Viatris Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Viatris Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Viatris Inc
These potential risks are based on the size, segment and geographies of the company.
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.